Scientific Programme
Track Information
 

 
Track 2: Pharmacokinetic/Pharmacodynamic Models, Biowaivers and Biosimilars


University of Petra,
Jordan


University Hospital Zurich, Switzerland


B. V. Patel Perd Centre, India


Jamia Hamdard, India


National University of Singapore, Singapore


Ege University, Turkey

 Time  Track
March  2, 2010
 (Tuesday)
 8:30-12:00
Track 2-1: Human/Animal Models in Oral Drug Absorption

Session Chair:

nasir

 

Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.

Session Co-Chair

:qw

Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.

8:30-8:35
Session Introduction
8:35-9:00ww

Title: Inter-individual Variability and Drug Development: BA/BE as Research Tool
Dr. Harish Padh, Director, B. V. Patel Perd Centre,
Thaltej-gandhinagar highway, Thaltej, Ahmedabad, India.

9:00-9:25aa

Title: Bioavailability Enhancement of Ropinirole by Using Nanoemulsion Based System
Dr. Sushama Talegaonkar, Department of Pharmaceutics,
Faculty of Pharmacy, Jamia Hamdard, New Delhi-110062, India.

9:25-9:50s

Title: The Importance of the Human Placenta Ex Vivo Perfusion Model in the Drug Development for Human Pregnancy
Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.

9:50-10:15

nasir

Title: Enhancement of Oral Bioavailability of Insulin in Humans
Dr. Nasir M. Idkaidek
,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.

10:15-10:25
Coffee Break
10:25-10:50gvSAfv

Title: Drug Discovery from Natural Toxins and on Animal models
Dr. P.Gopalakrishnakone
,
President, International Society on Toxinology,
Department of Anatomy & Venom and Toxin Research Programme,
Yong Loo Lin School of Medicine, National University of Singapore,
Lower Kent Ridge Road, Singapore.

10:50-11:15

Title: Human/Animal Models in Oral Drug Absorption
Dr. Ercument Karasulu
, Assoc.Professor, Ege University,
Center for Drug R&D and Pharmacokinetic Applications,
35100 Bornova, IZMIR, Turkey.

11:40-12:00
Panel Discussion


Renal Unit, UK


King Saud University,
Saudi Arabia


University Hospital Zurich, Switzerland


Hôpital Saint-Antoine, Paris


European Medicines Agency, UK


Alessandro Manzoni Hospital, Italy


Widener University, USA

 

March 2, 2010
(Tuesday)
13:00-18:00
Track 2-2: Biosimilars and Biowaivers
Session Chair: sf

Dr. David Goldsmith, Renal Unit, New Guy House, 
Guy's Hospital, London, UK.

Session Co-Chair:

khalid

 

 

Dr. Khalid Alkharfy,College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.

13:00-13:05
Session Introduction

13:05-13:30

khalid

 

 

Title:  Biosimilar Products Selection: Challenges for Clinicians
Dr. Khalid Alkharfy,College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.

13:30-13:55rfgwserg

Title: Drug Delivery in Pregnancy: Transport of Nanoparticles Across the Human Placenta and Fetal Exposure
Dr. Antoine Malek
, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.

13:55-14:20

Title: European Regulations in the Context of Biosimilars
Dr. Jean-Louis Prugnaud, Chef de Service,
Hôpital Saint-Antoine, 184 rue du Fbg Saint-Antoine,
Paris.

14:20-14:45

Title: Biosimilars and CHMP EU Scientific Aadvice
Dr. Efthymios Manolis
, Scientific Administrator,
Scientific Advice Human - Pre Authorisation Evaluation, EMEA,
7 Westferry Circus, Canary Wharf, London, UK.

14:45-16:20
Coffee Break & Poster Session
16:20-16:45

Title: Biosimilar of Epoetin Alfa: Issues on Comparability and Immumogenicity
Dr. Lucia Del Vecchio

Department of Nephrology and Dialysis,
A. Manzoni Hospital, Lecco, Italy.

16:45-17:10

aseg

Title: Biosimilars and Follow-on Biologics
Dr. Fuhr Joseph P, Widener University, One University Place, Chester, PA 19013, USA.

17:10-17:35sf

Title: Biosimilar Epoetins in Europe - A Success Story?
Dr. David Goldsmith, Renal Unit, New Guy House,
Guy's Hospital, London, UK.

17:35-18:00
Panel Discussion


GSB Life Sciences, USA


Stanford University School of Medicine, USA


Cairo University, Egypt


Lord Shiva College of Pharmacy, India


Kazusa DNA Research Institute, Japan


University of Edinburgh, UK


University at Buffalo, USA

March 2, 2010
 (Tuesday)
 8:30-12:00
Track 2-3: Biosimulation in BE Studies-Prediction Tools

Session Chair:

srinu

 

Dr. Srinubabu Gedela,
Stanford University School of Medicine, USA.

Session Co-Chair:

xzdvzdv

Prof. Hany A. El-Shemy, Director of Biotechnology Labs,
FARP, Biochemistry and Molecular Biology,
Biochemistry Department, Faculty of Agriculture,
Cairo University, 12613 Giza, Egypt.

8:30-8:35
Session Introduction

9:00-9:25

xzdvzdv

Title: In-Silico Selection of Natural Anti-leukaemia Compounds
Prof. Hany A. El-Shemy, Director of Biotechnology Labs,
FARP, Biochemistry and Molecular Biology,
Biochemistry Department, Faculty of Agriculture,
Cairo University, 12613 Giza, Egypt.

9:25-9:50

Title: In Silico Adme Prediction Using QSPR Studies
Dr. Yash Paul Singla,
Principal, Lord Shiva College of Pharmacy,
P.B. No.63, Near Civil Hospital, Sirsa-125055, Haryana, India.

9:50-10:15;pijno

Dr. Hsin-Yun HSU, Laboratory of Medical Genomics,
Department of Human Genome Research,
Kazusa DNA Research Institute, Kisarazu, Chiba, Japan.

10:15-10:25
Coffee Break
10:25-10:50sweg

Dr. Alexey Goltsov, Centre for Systems Biology of Edinburgh,
School of Biological Sciences, University of Edinburgh,
The Kings Buildings, Mayfield Road, Edinburgh, EH9 3JU, UK.

10:50-11:15dvsve

Title: Drug Delivery System for Proteins and Biosimilars
Dr. Sathy V. Balu-Iyer
, Associate Professor,
Department of Pharmaceutical Sciences, 521 Hochstetter Hall,
University at Buffalo, State University of New York,
Amherst, New York, USA.

11:40-12:00
Panel Discussion


Chungnam National University, Korea


Eli Lilly and Company, USA


Synchron Research Services Pvt. Ltd., India

March 2, 2010
 (Tuesday)
13:00-18:00
Track 2-4: Statistical Issues in BA/BE
Session Chair: egsehg

Prof. Kwang-il Kwon, College of Pharmacy,
Chungnam National University, Daejeon, Korea.

Session Co-Chair:egfa

Ms. Ying Grace Li, Project Statistician
Statistics-AI/ MSK/ CC/ CV, Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285, USA.

13:00-13:05
Session Introduction

13:05-13:30

egsehg

 

 

Title: Bioequivalence Methods for Assessment of Highly
Variable Drug – ABE, SABE, PBE and IBE
Prof. Kwang-il Kwon
, College of Pharmacy,
Chungnam National University, Daejeon, Korea.

13:55-14:20

egfa

 

Title: The Application of Bayesian/Frequentist Analysis in Bioequivalence/Bioavailability Studies
Ms. Ying Grace Li
, Project Statistician,
Statistics-AI/ MSK/ CC/ CV, Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285, USA.

14:45-16:20
Coffee Break & Poster Session
16:20-16:45srdh

Title: Sparse Sampling Strategies in Pharmacokinetics and Bioequivalence
Dr. Shubha Rani
,
Technical Director & Head - Biometrics and Data Management,
Synchron Research Services Pvt. Ltd.,
'The chambers', 3rd Floor, Bodakdev, SG Highway,
Ahmedabad, India.

17:35-18:00
Panel Discussion


Rhodes University,
South Africa



Harvard Medical School, USA


Cadila Pharmaceuticals Limited, India


University of Trieste, Italy


University of Hyderabad,
India

 

March 2, 2010
 (Tuesday)
 8:30-12:00
Track 2-5: In Vivo/In Vitro Methods to Determine Bioavailability

Session Chair:

isdore

 

Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.

Session Co-Chair:

Dr. Luis Pereira, Associate Professor,
Pharmacometrics MCPHS, Childrens' Hospital Boston,
Harvard Medical School, Boston, MA, USA.

8:30-8:35
Session Introduction

9:25-9:50

nbnvn

 

 

Title: Average, Individual and Population Bioequivalence – Understanding the True Variability of a Product
Dr. Bhaswat S. Chakraborty
, Sr. Vice President, R&D,
Cadila Pharmaceuticals, India.

9:50-10:15rg

Title: Bioavailability of  Flavonoids: In Vitro Methods for Assessing Bilitranslocase-Mediated Membrane Transport
Dr. Sabina Passamonti
, University of Trieste,
Department of Life Sciences, via L. Giorgieri 1, 34127 Trieste,
Italy.

10:15-10:25
Coffee Break
10:25-10:50

Title: Quantitation of Alpha Amyrin in Scoparia dulcis L. Whole Plant Extract by High Performance Liquid Chromatography
Dr. Kishore Kumar Kadimpati, Dept. Of Plant Sciences,
School of Life Sciences, University of Hyderabad, Gochibowli,
Hyderabad, India.

10:50-11:15

isdore

 

Title: Application of Dermal Microdialysis for the Determination of Bioavailability/Bioequivalence of Topical Drug Products Not Intended for Systemic Circulation
Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.

11:15-11:40

Dr. Luis Pereira, Associate Professor,
Pharmacometrics MCPHS, Childrens' Hospital Boston,
Harvard Medical School, Boston, MA, USA.

11:40-12:00
Panel Discussion


Pharmaceutics International, Inc, USA


Division of Product Quality Research, USA


College of Pharmaceutical Sciences, India


Shreemati Nathibai Damodar Thackersey Women's University, India


Maharashtra Institute of Pharmacy, India



March 2, 2010
 (Tuesday)
 13:00-18:00
Track 2-6: Role of Drug Delivery Systems in Bioequivalence and Bioavailability

Session Chair:

praveen

 

Dr. Praveen S. Hiremath, Pharmaceutics Int., Inc., USA.

Session Co-Chair: sxdvb

Dr. Mansoor A. Khan,
Director, Division of Product Quality Research,
FDA/CDER/OPS/OTR, White Oak, LS Building 64,
10903 New Hampshire Ave, Silver Spring, MD, USA.

13:00-13:05
Session Introduction

13:05-13:30

praveen

 

 

Title: Role of Lipid Based Drug Delivery Systems in Bioavailability Enhancement
Dr. Praveen S. Hiremath, Product Development,
Pharmaceutics International, Inc., 10189 Gilroy Road,
Hunt Valley, MD, USA.

13:30-13:55sxdvb

Dr. Mansoor A. Khan,
Director, Division of Product Quality Research,
FDA/CDER/OPS/OTR, White Oak, LS Building 64,
10903 New Hampshire Ave, Silver Spring, MD, USA.

13:55-14:20vsxdbv

Title: Bioavailability and Bioequivalence of Novel Drug Delivery Systems
Dr. N. Udupa, Professor and Principal,
College of Pharmaceutical Sciences, MAHE, Manipal, India.

14:20-14:45dxfbn

Title: Nanosuspensions for Improved Drug Bioavailability and Targeted Drug Delivery
Prof. Kamalinder.K.Singh,
Principal(Addl. Charge), C.U.Shah College Of Pharmacy,
SNDT Women's University, Santacruz (West),
Mumbai - 400049, India.

14:45-16:20
Coffee Break & Poster Session
16:20-16:45

Dr. Rajeev Raghuvanshi,

17:10-17:35awef

Title: Enhancing Oral Bioavailabilty of Drugs Using Cyclodextrins
Dr. B.S.Kuchekar, Maharashtra Institute of Pharmacy,
MIT Campus, Paud Road, Kothrud, Pune. Maharashtra, India.

17:35-18:00
Panel Discussion
 
Track 3: Bioanalytical Methodology Development and Validation Using HPLC and LCMS


Agilent Technologies India Pvt. Ltd., India


Aizant Drug Research Solutions, India


Central Drug Research Institute, India


University of Athens,
Greece


Jadavpur University,
India

 Time  Track
March 2, 2010
 (Tuesday)
  8:30-12:00
Track 3-1: Advances in Mass Spectrometry Methodology Development

Session Chair:

ajith

 

Dr. Ajit Srivastava
Business Manager - LCMS, Agilent Technologies India Pvt. Ltd,
Plot No 10, Udyog Vihar, Phase IV, Gurgaon – 122016, India.

Session Co-Chair:seg

Dr. S. Ravisankar, PhD, MBA,
Director, Quality Assurance, Clinical Development,
GVK Biosciences Pvt Ltd, India.

8:30-8:35
Session Introduction
8:35-9:00seg

Title: Recent Developments in Bioanalytical Method Validation Requirements for Mass Spectrometric Methods
Dr. S. Ravisankar, PhD, MBA,
Director, Quality Assurance, Clinical Development,
GVK Biosciences Pvt Ltd, India.

9:00-9:25

 

ajith

 

Dr. Ajit Srivastava
Business Manager - LCMS, Agilent Technologies India Pvt. Ltd,
Plot No 10, Udyog Vihar, Phase IV, Gurgaon – 122016, India.

9:25-9:50

Title: Bioanalytical Method Transfer: Challenges and Recent Developments
Dr.Yarramraju Sitaramaraju, Associate director,
Clinical Development, Aizant Drug Research Solutions P. Ltd.,
Hyderabad, India.

9:50-10:15dv

Title: Ion Trap as a Tool for In-vitro and In-vivo Metabolite Profiling
Dr. Girish kumar jain,
Head, Division of Pharmacokinetics & Metabolism,
Central Drug Research Institute, Lucknow-226001, India.

10:15-10:25
Coffee Break
10:50-11:15

Title: Bioanalytical Methodology Development and Validation Using HPLC and LCMS-Advances in Mass Spectrometry Methodology Development
Dr. Constantinos Pistos, Lecturer of Toxicology,
Laboratory of Forensic Medicine and Toxicology,
Medical School, University of Athens, Greece.

11:15-11:40zdxvbv

Title: Bioanalytical Method Development of the Metabolite 3-desmethylthiocolchicine in Human Plasma by LC-MS/MS
Dr. Sangita Agarwal
, Women Scientist-DST,
Dept. of Pharm. Tech., Jadavpur University, Kolkata, India.

11:40-12:00
Panel Discussion


Universiade Federal da Bahia, Brazil


Defence Research and Development, Canada


Cairo University, Egypt


University of Region of Cariri, Brazil


Central Drug Research Institute, India


Tabriz University of Medical Sciences, Iran

 

 

 

March 2, 2010
 (Tuesday)
13:00-18:00
Track 3-2: Antiviral, Anti Retroviral, Antibacterial and Anti Fungal Drugs  
Session Chair: Call for Host
Session Co-Chair: Call for Co-Host
13:00-13:05 Session Introduction
13:05-13:30

Dr. Silvia Lima Costa,
Laboratorio de Neuroquimica e Biologia Celular,
Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil.

13:30-13:55

vcvcv

Title: Protection against Seasonal and Avian Influenza Virus Infections Using Nucleic Acid-Based Antiviral Agents
Dr. Jonathan P. Wong, Defence Scientist,
Defence Research and Development Canada, Suffield,
CP 4000, Succ. Main, Medicine Hat, Alberta, Canada.

13:55-14:20

vcv

Title: Biochemical and Biological Studies on Salt Stressed Spirulina Platensis
Dr. Emad A. Shalaby
,
Biochemistry Department, Faculty of Agriculture and
Botany Department, Faculty of Science, Cairo University,
Giza, Egypt.

14:20-14:45

Title: The Necessity of New Sinergistic Formulations to Combat the Drug Resistance
Dr. Henrique Douglas Coutinho,
Laboratory of Microbiology and Molecular Biology,
Depart. of Biological Sciences,
University of Region of Cariri - URCA, AV. Cel Antonio Luiz,
Crato (CE), Brazil.

14:45-16:20 Coffee Break & Poster Session

16:20-16:45

jawha

Title: Standardization of Herbal Drug Preparations using LC-MS
Dr. Jawahar Lal, Scientist E-II,
Pharmacokinetics & Metabolism Division,
Central Drug Research Institute, CSIR, Lucknow, India.

16:45-17:10

Dr. Mohammadreza Ghandforoush-Sattari,
Assistant Professor of Clinical Toxicology,
Dept.Pharmacology & Toxicology, Faculty of Pharmacy,
Tabriz University of Medical Sciences, Tabriz, Iran.

17:35-18:00 Panel Discussion


Hopital Cochin, Paris


Johns Hopkins University, USA


Albert Einstein Medical Center, USA


Yeditepe University, Turkey


March 2, 2010
 (Tuesday)
8:30-12:00
Track 3-3: Drugs Acting on Central Nervous Systems  
Session Chair: Call for Host
Session Co-Chair:

Dr. Raphael Serreau, MD, Responsable Appel d'Offre - PV,
URC Paris Necker-Cochin- EA 3620, Hopital Cochin, Paris.

8:30-8:35 Session Introduction
8:35-9:00

Title: Bioequivalence of generic antiepilepsy drugs
Dr. Gregory Krauss, MD, Professor of Neurology,
Johns Hopkins University, Baltimore, MD, USA.

9:25-9:50

bvb

Title: Codeine and Breastfeeding, What are the Latest Data in Pharmacovigilance and EMEA Regulation
Dr. Raphael Serreau
, MD, Responsable Appel d'Offre - PV,
URC Paris Necker-Cochin- EA 3620, Hopital Cochin, Paris.

9:50-10:15

Dr. S. Chattopadhyay

10:15-10:25 Coffee Break
10:50-11:15

Dr. Darshak Karia, MD, Director, Heart Failure Services,
Einstein Heart and Vascular Institute, Levy 3 East,
Albert Einstein Medical Center, Philadelphia, USA.

11:15-11:40

Title: Clinical Study of the Bioequivalence of Trimetazidine Immediate Release and Modified Release Tablets
Dr. Dilek Erol, Yeditepe University, Faculty of Pharmacy, 34755 Kayısdagı, Istanbul, Turkey.

11:40-12:00 Panel Discussion


University of Hyderabad,
India


Boys Town National Research Hospital, USA


V.L. College of Pharmacy, India


University of Wisconsin-Whitewater, USA


University of Nebraska Medical Center, USA


Creighton University Medical Center, USA


Osmania University, India

 

March 2, 2010
 (Tuesday)
13:00-18:00
Track 3-4: Anticancer/Anti-Neovascular Drugs

Session Chair:

vbvb

Prof. P. Reddanna,
Eicosanoids, Inflammation & Cancer Research Group,
School of Life Sciences, University of Hyderabad, Hyderabad, India.

Session Co-Chair:

bvb

Dr. Sudhakar Akulapalli, Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, USA.

13:00-13:05 Session Introduction

13:05-13:30

b vb

Title: Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Prof. Mayur Yergeri, Department of Medicinal Chemistry,
V.L. College of Pharmacy, Raichur, India.

13:30-13:55

bnb

Title: Signaling Mechanisms of Endogenous Anti-cancer Molecules Derived From Extra Cellular Matrix Type IV Collagen
Dr. Sudhakar Akulapalli
, Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, USA.

13:55-14:20

Title: Expanding Applications for Use of Biologically Modified Nanoparticles in Cancer Research
Dr. Eric Michael Bratsolias Brown, Assistant Professor,
Department of Biological Sciences,
University of Wisconsin-Whitewater, Upham Hall,
800 W. Main St., Whitewater, WI 53190, USA.

14:20-14:45

radhna

Title: Imatinib Resistance in Chronic Myeloid Leukemia:
Role of COX-2, MDR-1 and HDACs
Prof. P. Reddanna
,
Eicosanoids, Inflammation & Cancer Research Group,
School of Life Sciences, University of Hyderabad, Hyderabad, India.

14:45-16:20 Coffee Break & Poster Session

16:20-16:45

 

kollu

Title: Phosphorylation of eIF2α-Mediated Signalling Pathways in Cell Survival and Suicide
Prof. Kolluru VA Ramaiah, Dept of Biochemistry,
School of Life Sciences, University of Hyderabad
Hyderabad, India.

16:45-17:10

suray

Title: Differential Regulation of HIF-1α under Normoxic and Hypoxic Conditions 
Dr. Surya S. Singh
, Dept. of Biochemistry,
Osmania University, Hyderabad, India.

17:35-18:00 Panel Discussion
 
Track 4: IP, Regulatory Affairs and Outsourcing Alliance


University of Pisa, Italy


KLE University, India


March 2, 2010
 (Tuesday)
13:00-18:00
Track 4-1: ICH/FDA Guidelines and Regulatory Updates   
Session Chair:

Prof. Mario Giorgi, Pharmacology & Toxicology Section,
University of Pisa, V.le delle Piagge 2, 56124 Pisa, Italy.

Session Co-Chair:

basava

Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.

13:00-13:05 Session Introduction

13:30-13:55

mario

Title: PK-PD integration/modeling of NSAID in Veterinary Pharmacology
Prof. Mario Giorgi
, Pharmacology & Toxicology Section,
University of Pisa, V.le delle Piagge 2, 56124 Pisa, Italy.

14:45-16:20 Coffee Break & Poster Session

16:20-16:45basava

 

 

 

Title: Regulatory Requirements for Orphan Drugs Delivery
Prof. Basavaraj K. Nanjwade
, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.

17:35-18:00 Panel Discussion


Clinical Research and Biosciences division, India


Raptakos, Brett & Co. Ltd., India


PharMantra Consulting Solutions, India


The Islamia University of Bahawalpur, Pakistan

March 2, 2010
 (Tuesday)
13:00-18:00
Track 4-2: Perspectives of Regulatory Agencies, Worldwide, on Bioequivalence Testing
Session Chair:

Ms. Neerja S, Dy. Manager, QA, RA Chem Pharma Ltd,
Clinical Research and Biosciences division,
C3 (A) HUDA complex, Tarnaka, Hyderabad, India.

Session Co-Chair:

Dr. Pralhad Tayade, DGM Contract Research,
Raptakos Brett & Co., Mumbai, India.

13:00-13:05 Session Introduction

13:05-13:30

rajini

Title: Assuring Bioequivalence: Pilot Studies or Dissolution?
Dr. Ranjani Nellore
, RAC, PharMantra Consulting Solutions,
Hyderabad, India.

13:30-13:55

Title: Challenges for Preparation of Module 2 & 5 for BA/ BE for US & EMEA
Ms. Neerja S
, Dy. Manager, QA, RA Chem Pharma Ltd,
Clinical Research and Biosciences division,
C3 (A) HUDA complex, Tarnaka, Hyderabad, India.

14:20-14:45

Title: What Should be Indian Pharma R&D’s Focus Areas in 2010
Dr. Pralhad Tayade, DGM Contract Research,
Raptakos Brett & Co., Mumbai, India.

14:45-16:20 Coffee Break & Poster Session
16:45-17:10

Title: In-Vitro Release and Pharmacokinetics of Anti-tubercle
Drug Ethionamide in Healthy Male Subjects
Prof. Mahmaood Ahmad
,
Dean, Faculty of Pharmacy and Alternative Medicine,
The Islamia University of Bahawalpur, Punjab, Pakistan.

17:35-18:00 Panel Discussion
Participants List
(Academia)
University of Notre Dame, USA

Faculty of Medicine Siriraj Mahidol University, Thailand

Nova Southeastern University, USA

The Australian National University Medical School, University of Canberra, Australia

University of Hyderabad, India

Panjab University, Chandigarh, India

Institute of Biotechnology and Antibiotics, Warsaw, Poland

Texas Tech School of Pharmacy, USA

University of Petra, Jordan

Jadavpur University, India

University of British Columbia, Canada

Canadian Society for Pharmaceutical Sciences, Canada

National University of Singapore, Singapore

King Saud University, Saudi Arabia

Widener University, USA

Stanford University School of Medicine, USA

University at Buffalo, State University of New York, USA

School of Biological Sciences, University of Edinburgh, UK

Chungnam National University, Korea

Harvard Medical School, USA

Polish Academy of Sciences, Poland

University of Trieste, Italy

College of Pharmaceutical Sciences, MAHE, India

Medical School, University of Athens, Greece

Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil

University of Region of Cariri - URCA, Brazil

Tabriz University of Medical Sciences, Iran

Johns Hopkins University, USA

Creighton University Medical Center and University of Nebraska Medical Center, USA

University of Pisa, Italy

The University of Liverpool, UK

The Islamia University of Bahawalpur, Pakistan

University of California, Sanfransisco, USA

Al-Qassim University, College of Pharmacy Buraidah, Saudi Arabia

University of Madras, India

SRM University NCR Campus, India

University of Peradeniya, Sri Lanka

Yokohama City University, Graduate School of Medicine, Japan

Radboud University Nijmegen Medical Center, The Netherlands

Qilu Hospital of Shandong University, China

Meerut Institute of Engineering and Technology, India

Florida A & M University, College of Pharmacy, USA

Jawaharlal Nehru Technological University, India

Ludwig-Maximilians University, Germany

V.L. College of Pharmacy, India

University of Alberta, Canada

Panjab University, India

Monash Institute of Pharmaceutical Sciences, Monash University, Australia

University of British Columbia, Brain Research Centre, Canada

Univ Inst Pharm Sci (UGC Center of Adv Studies), Panjab University, India

Institut Supérieur de Biotechnologies de Sfax, Tunisie

All India Institute of Medical Sciences, India

Rhodes University, South Africa

Université Paris, France

Faculty of Pharmacy, University of Ljubljana Askerceva 7, Slovenia

Chungnam National University, Korea

Dr H S Gour University, India

National School of Public Health, Ministry of Health, Brazil

University of Toronto, Canada

Oncology Institute of Vojvodina , Serbia

Indian Institute of Chemical Technology, India

Indian Institute of Toxicology Research, India

Einstein Heart and Vascular Institute, Albert Einstein Medical Center, USA

University of Texas at Austin, USA

National Institute for Research in Reproductive Health (ICMR), India

National Cancer Institute, USA


Participants List
(Business)
US Pharmacopeia, USA

Food and Drug Administration, USA

University Hospital Zurich, Switzerland

B. V. Patel Perd Centre, India

Guy's Hospital, UK

Hôpital Saint-Antoine, Paris

A. Manzoni Hospital, Italy

Kazusa DNA Research Institute, Japan

Pharmaceutics Int., Inc., USA

Agilent Technologies, USA

Central Drug Research Institute, India

EMF Consulting, France

Hopital Cochin, Paris

Boys Town National Research Hospital, Omaha, USA

Aurobindo Pharma Ltd., India

Abbott labs, USA

Synthon BV, The Netherlands

Children's Hospital Medical Center, USA

Piramal Life Sciences, India

AstraZeneca R&D Mölndal, Sweden

Sun Pharma Advanced Research Company Limited, India

Ranbaxy Research Laboratories, India

University Children's Hospital Basel UKBB, Switzerland

Huashan hospital of Fudan University, China

Novartis Institutes for BioMedical Research, USA

Defence Research and Development Canada Suffield, Canada

Saudi Food and Drug Authority, Saudi Arabia

Cetero Research, USA

Panacea Biotec Ltd., India

Lupin Ltd., India